Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Does Dietary Fiber Affect the Levels of Nutritional Components After Feed Formulation?
fibers Article Does Dietary Fiber Affect the Levels of Nutritional Components after Feed Formulation? Seidu Adams 1 ID , Cornelius Tlotliso Sello 2, Gui-Xin Qin 1,3,4, Dongsheng Che 1,3,4,* and Rui Han 1,3,4 1 College of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, China; [email protected] (S.A.); [email protected] (G.-X.Q.); [email protected] (R.H.) 2 College of Animal Science and Technology, Department of Animal Genetics, Breeding and Reproduction, Jilin Agricultural University, Changchun 130118, China; [email protected] 3 Key Laboratory of Animal Production, Product Quality and Security, Jilin Agricultural University, Ministry of Education, Changchun 130118, China 4 Jilin Provincial Key Laboratory of Animal Nutrition and Feed Science, Jilin Agricultural University, Changchun 130118, China * Correspondence: [email protected]; Tel.: +86-136-4431-9554 Received: 12 January 2018; Accepted: 25 April 2018; Published: 7 May 2018 Abstract: Studies on dietary fiber and nutrient bioavailability have gained an increasing interest in both human and animal nutrition. Questions are increasingly being asked regarding the faith of nutrient components such as proteins, minerals, vitamins, and lipids after feed formulation. The aim of this review is to evaluate the evidence with the perspective of fiber usage in feed formulation. The consumption of dietary fiber may affect the absorption of nutrients in different ways. The physicochemical factors of dietary fiber, such as fermentation, bulking ability, binding ability, viscosity and gel formation, water-holding capacity and solubility affect nutrient absorption. The dietary fiber intake influences the different methods in which nutrients are absorbed. -
Anthem Blue Cross Drug Formulary
Erythromycin/Sulfisoxazole (generic) INTRODUCTION Penicillins ...................................................................... Anthem Blue Cross uses a formulary Amoxicillin (generic) (preferred list of drugs) to help your doctor Amoxicillin/Clavulanate (generic/Augmentin make prescribing decisions. This list of drugs chew/XR) is updated quarterly, by a committee Ampicillin (generic) consisting of doctors and pharmacists, so that Dicloxacillin (generic) the list includes drugs that are safe and Penicillin (generic) effective in the treatment of diseases. If you Quinolones ..................................................................... have any questions about the accessibility of Ciprofloxacin/XR (generic) your medication, please call the phone number Levofloxacin (Levaquin) listed on the back of your Anthem Blue Cross Sulfonamides ................................................................ member identification card. Erythromycin/Sulfisoxazole (generic) In most cases, if your physician has Sulfamethoxazole/Trimethoprim (generic) determined that it is medically necessary for Sulfisoxazole (generic) you to receive a brand name drug or a drug Tetracyclines .................................................................. that is not on our list, your physician may Doxycycline hyclate (generic) indicate “Dispense as Written” or “Do Not Minocycline (generic) Substitute” on your prescription to ensure Tetracycline (generic) access to the medication through our network ANTIFUNGAL AGENTS (ORAL) _________________ of community -
Mineral Absorption & Deficiency
Mineral Absorption & Deficiency Mineral Absorption and Deficiency By Yvette R. Schlussel, Ph.D. Rutgers University Summary Conclusions A wide range of minerals is essential for human health. The recommended dietary allowances (RDAs) serve as guidelines for daily intakes of nutrients that population groups in the United States should have in their diets. Dietary Reference Intakes (DRIs) have been established for the following essential minerals: calcium, phosphorus, and magnesium. In addition, DRIs have been set for other trace elements, which have been identified to have important-if not essential roles in maintaining health. These include: iron, zinc, copper, manganese, selenium, boron, chromium, cobalt, molybdenum, vanadium, nickel, lithium, iodine and fluoride(1). There is evidence that the need for mineral intake is not being met, especially in certain subpopulations. It is difficult for most individuals to ingest enough calcium from foods available in a cereal-based economy without liberal consumption of dairy products, for example.(2) Supplementation with minerals is recommended to complement dietary intake and avoid deficiencies. (3) Mineral supplements are associated with different absorptive capacities. The absorption of minerals depends on a number of physiological, biochemical, and hormonal characteristics of the consumer and the form of the mineral consumed. Potential mineral sources are not all alike and should be evaluated for bioavailability.(4) Factors that enhance mineral absorption include the form of the mineral ingested, maintenance of chemical stability, presence of a specific transporter, small particle size, solubility, ascorbic acid, and low intestinal motility. Factors that inhibit absorption include oxalic acid, phytic acid, (5) fiber(6), sodium, tannins(7), caffeine, protein, fat, antacids, rapid transit time, malabsorption syndromes, precipitation by alkalinization, other minerals(8), hormones and nutritional status(9). -
Drug Consumption in 2017 - 2020
Page 1 Drug consumption in 2017 - 2020 2020 2019 2018 2017 DDD/ DDD/ DDD/ DDD/ 1000 inhab./ Hospital 1000 inhab./ Hospital 1000 inhab./ Hospital 1000 inhab./ Hospital ATC code Subgroup or chemical substance day % day % day % day % A ALIMENTARY TRACT AND METABOLISM 322,79 3 312,53 4 303,08 4 298,95 4 A01 STOMATOLOGICAL PREPARATIONS 14,28 4 12,82 4 10,77 6 10,46 7 A01A STOMATOLOGICAL PREPARATIONS 14,28 4 12,82 4 10,77 6 10,46 7 A01AA Caries prophylactic agents 11,90 3 10,48 4 8,42 5 8,45 7 A01AA01 sodium fluoride 11,90 3 10,48 4 8,42 5 8,45 7 A01AA03 olaflur 0,00 - 0,00 - 0,00 - 0,00 - A01AB Antiinfectives for local oral treatment 2,36 8 2,31 7 2,31 7 2,02 7 A01AB03 chlorhexidine 2,02 6 2,10 7 2,09 7 1,78 7 A01AB11 various 0,33 21 0,21 0 0,22 0 0,24 0 A01AD Other agents for local oral treatment 0,02 0 0,03 0 0,04 0 - - A01AD02 benzydamine 0,02 0 0,03 0 0,04 0 - - A02 DRUGS FOR ACID RELATED DISORDERS 73,05 3 71,13 3 69,32 3 68,35 3 A02A ANTACIDS 2,23 1 2,22 1 2,20 1 2,30 1 A02AA Magnesium compounds 0,07 22 0,07 22 0,08 22 0,10 19 A02AA04 magnesium hydroxide 0,07 22 0,07 22 0,08 22 0,10 19 A02AD Combinations and complexes of aluminium, 2,17 0 2,15 0 2,12 0 2,20 0 calcium and magnesium compounds A02AD01 ordinary salt combinations 2,17 0 2,15 0 2,12 0 2,20 0 A02B DRUGS FOR PEPTIC ULCER AND 70,82 3 68,91 3 67,12 3 66,05 4 GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 0,17 7 0,74 4 1,10 4 1,11 5 A02BA02 ranitidine 0,00 1 0,63 3 0,99 3 0,99 4 A02BA03 famotidine 0,16 7 0,11 8 0,11 10 0,12 9 A02BB Prostaglandins 0,04 62 -
The Mineral Composition of Wild-Type and Cultivated Varieties of Pasture Species
agronomy Article The Mineral Composition of Wild-Type and Cultivated Varieties of Pasture Species Tegan Darch 1,* , Steve P. McGrath 2 , Michael R. F. Lee 1,3 , Deborah A. Beaumont 1 , Martin S. A. Blackwell 1, Claire A. Horrocks 1, Jessica Evans 4 and Jonathan Storkey 2 1 Sustainable Agriculture Sciences, Rothamsted Research, North Wyke, Okehampton, Devon EX20 2SB, UK; [email protected] (M.R.F.L.); [email protected] (D.A.B.); [email protected] (M.S.A.B.); [email protected] (C.A.H.) 2 Sustainable Agriculture Sciences, Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK; [email protected] (S.P.M.); [email protected] (J.S.) 3 Bristol Veterinary School, University of Bristol, Langford, Somerset BS40 5DU, UK 4 Computational and Analytical Sciences, Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK; [email protected] * Correspondence: [email protected] Received: 21 August 2020; Accepted: 22 September 2020; Published: 24 September 2020 Abstract: Mineral deficiencies in livestock are often prevented by using prophylactic supplementation, which is imprecise and inefficient. Instead, the trend for increased species diversity in swards is an opportunity to improve mineral concentrations in the basal diet. Currently, there are limited data on the mineral concentrations of different species and botanical groups, particularly for I and Se, which are among the most deficient minerals in livestock diets. We grew 21 pasture species, including some cultivar/wild type comparisons, of grasses, legumes and forbs, as single species stands in a pot study in a standard growth medium. -
(12) United States Patent (10) Patent No.: US 6,187,331 B1 Itoh Et Al
USOO6187331B1 (12) United States Patent (10) Patent No.: US 6,187,331 B1 Itoh et al. (45) Date of Patent: Feb. 13, 2001 (54) COMPOSITION FOR PROPHYLAXIS AND/ 5-508655 12/1993 (JP). OR TREATMENT OF DRY SYNDROME WO 96/29079 9/1996 (WO). COMPRISING WITAMIN ID WO 97/18817 5/1997 (WO). WO 98/51313 11/1998 (WO). (75) Inventors: Seiji Itoh, Mobara; Yasuo Ishii, OTHER PUBLICATIONS Kawaguchi; Katsuhiko Mukai, Kashiwa; Kiyoshi Kita, Tokyo, all of Leslie Bendra Sabbagh, “Sunlight May be Enemy of Heal (JP) ing Excimer PRK', Ocular Surgery News, vol. 9, No. 11, pp. 21–22, Jun. 1, 1991. (73) Assignee: New Vision Co., Ltd., Tokyo (JP) The Vitamins, pp. 54–55, 104-115, 150-177, 206–221, Academic Press, Inc.,1992. (*) Notice: Under 35 U.S.C. 154(b), the term of this Dryeye Brochure, pp. 10-13, Nippon Hyoronsha, Japan, patent shall be extended for 0 days. 1992. Paul Riordan-Eva, “Preventive Ophthalmology”, Appleton (21) Appl. No.: 09/575,987 & Lange, pp. 388-395, 1993. Ganka New Insight 5, pp. 132-143, Medical View-sha, (22) Filed: May 23, 2000 Japan, 1995. (Under 37 CFR 1.47) Olive Sheets et al., “The Effect of Ultra-Violet Rays on Rats, Deprived of Vitamine A in Their Diet”, Scientific Proceed Related U.S. Application Data ings, vol. 20, pp. 80-81, 1992. G. F. Powers et al., “The Influence of Light and Darkness (63) Continuation of application No. 08/872,052, filed on Jun. Upon the Development of exerophthalmia in the Rat', 10, 1997. Scientific Proceedings, vol. -
Estonian Statistics on Medicines 2006–2010
Ravimiamet State Agency of Medicines Eesti ravimistatistika 2006–2010 Estonian Statistics on Medicines 2006–2010 1 Toimetanud/ Edited by: Aivi Themas, Ott Laius Autoriõigus/ Copyright: Ravimiamet, 2011 Väljaande andmete kasutamisel või tsiteerimisel palume viidata allikale. When using or quoting the data included in this issue, please indicate the source. Kirjastanud/ Published by: Ravimiamet State Agency of Medicines Nooruse 1, 50411 Tartu Telefon 737 4140 Faks 737 4142 E-post [email protected] Trükkinud/Printed by: OÜ Paar ISSN 1736-5813 2 Eessõna Foreword Käesolev raamat on statistiline kokkuvõte This book is a statistical summary of the ravimikasutamise andmetest Eestis aastatel Estonian drug consumption data in 2006 – 2006–2010. Tulemused põhinevad ravimite 2010. The figures included in the book rep- hulgimüüjate esitatud aruannetel, mis kajas- resent sales from the wholesalers to gene- tavad ravimite müüki üld- ja haiglaapteeki- ral and hospital pharmacies and to other dele ning teistele asutustele (riigi- ja teadus- institutions (state- and scientific institu- asutused). tions). Eesti ravimikasutamise andmete võrrelda- In order to provide better possibilities for shar- vuse tagamiseks teiste riikidega on tulemu- ing experiences and making international sed esitatud anatoomilis-terapeutilis-keemi- comparisons, the Anatomical-Therapeutic- lise (ATC) klassifikatsiooni alusel, definee- Chemical (ATC) classification of medicines ritud päevadooside arvuna tuhande inimese and the Defined Daily Dose (DDD) methodo- kohta ööpäevas (DPD/1000/ ööpäevas). logy recommended by the World Health Defineeritud päevadoos (DPD) on kokku- Organization is used. The DDD is the leppeline suurus, mis on Maailma Tervise- assumed average dose per day for the drug organisatsiooni (WHO) poolt välja töötatud used in its main indication in adults. -
Plant Mineral Nutrition - Accessscience from Mcgraw-Hill Education
Plant mineral nutrition - AccessScience from McGraw-Hill Education http://accessscience.com/content/plant-mineral-nutrition/523500 (http://accessscience.com/) Article by: Mattson, Neil S. Department of Horticulture, Cornell University, Ithaca, New York. Last updated: 2014 DOI: https://doi.org/10.1036/1097-8542.523500 (https://doi.org/10.1036/1097-8542.523500) Content Hide Discovery of essential nutrients Absorption of nutrients by plants Links to Primary Literature Function of specific nutrients Absorption of nutrients into roots Additional Readings Nutrient deficiencies and toxicities Nutrient distribution The processes involved in plant assimilation and metabolism of all chemical elements, with the exception of carbon, hydrogen, and oxygen. The latter elements are typically excluded from the discussion of plant mineral nutrition because they are assimilated from the atmosphere and from water. Mineral nutrients are so named because they are primarily derived from the weathering of minerals of the Earth's crust, with the exception of nitrogen, which is primarily derived from atmospheric nitrogen. Taken together, these nutrient elements are critical for the processes of plant growth and hence are key to the capturing of solar energy, which is the basis of nearly all life on Earth. See also: Plant growth (/content/plant-growth /523000); Plant metabolism (/content/plant-metabolism/523400); Plant physiology (/content/plant-physiology/524500) Discovery of essential nutrients In 1699, John Woodward reported that spearmint grown in rainwater grew more poorly than plants grown in water with soil or rotting leaves. Water culture (hydroponic) techniques were subsequently employed to characterize the nature of how plants gained matter. In the nineteenth century, Justus von Liebig advanced the notion that soil per se was not required for plant growth, but that it contributed soluble inorganic constituents. -
Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 63 (2003), pp. 1483–1490 Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism STUART M. SPRAGUE,FRANCISCO LLACH,MICHAEL AMDAHL,CAROL TACCETTA, and DANIEL BATLLE Division of Nephrology/Hypertension and Department of Medicine, Northwestern University Feinberg School of Medicine, Evanston and Chicago, Illinois; Georgetown University Medical School, Washington, D.C.; and Abbott Laboratories, North Chicago, Illinois Paricalcitol versus calcitriol in the treatment of secondary hyper- Osteitis fibrosa cystica, resulting from poorly con- parathyroidism. trolled secondary hyperparathyroidism, remains a com- Background. Management of secondary hyperparathyroid- mon manifestation of renal osteodystrophy and causes ism has included the use of active vitamin D or vitamin D ana- logs for the suppression of parathyroid hormone (PTH) secre- significant morbidity in patients with chronic renal fail- tion. Although, these agents are effective, therapy is frequently ure [1, 2]. Decreased renal production of calcitriol (1,25 limited by hypercalcemia, hyperphosphatemia, and/or eleva- vitamin D ), hypocalcemia, and hyperphosphatemia are ϫ 3 tions in the calcium-phosphorus (Ca P) product. In clinical the major contributing factors to the development of studies, paricalcitol was shown to be effective at reducing PTH concentrations without causing significant hypercalcemia or secondary hyperparathyroidism [1, 3–5]. Calcitriol is syn- hyperphosphatemia as compared to placebo. A comparative thesized from previtamin D3 by hydroxylation on carbons study was undertaken in order to determine whether paricalci- 25 and 1 in the liver and kidney, respectively [6]. The tol provides a therapeutic advantage to calcitriol. -
The Influence of Protein on the Absorption of Iron, Copper, and Zinc in Adult Women
University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-1965 The Influence of Protein on the Absorption of Iron, Copper, and Zinc in Adult Women Polly Givler Martin University of Tennessee, Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Nutrition Commons Recommended Citation Martin, Polly Givler, "The Influence of Protein on the Absorption of Iron, Copper, and Zinc in Adult Women. " PhD diss., University of Tennessee, 1965. https://trace.tennessee.edu/utk_graddiss/3760 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Polly Givler Martin entitled "The Influence of Protein on the Absorption of Iron, Copper, and Zinc in Adult Women." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Nutrition. Frances A. Schofield, Major Professor We have read this dissertation and recommend its acceptance: Tom R. Savage, John T. Smith, Bernadine Meyer, Mary Rose Gram Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) November 15, 1965 To the Graduate Council: I am submitting herewith a dissertation written by Polly Givler Martin entitled "The Influence of Protein on the Absorption of Iron, Copper, and Zinc in Adult Women. -
Citric Acid in the Nutrient Solution Increases the Mineral Absorption in Potted Tomato Grown in Calcareous Soil
Pak. J. Bot., 48(1): 67-74, 2016. CITRIC ACID IN THE NUTRIENT SOLUTION INCREASES THE MINERAL ABSORPTION IN POTTED TOMATO GROWN IN CALCAREOUS SOIL FABIÁN PÉREZ-LABRADA, ADALBERTO BENAVIDES-MENDOZA*, LUIS ALONSO VALDEZ-AGUILAR AND VALENTÍN ROBLEDO-TORRES Universidad Autónoma Agraria Antonio Narro, Departamento de Horticultura, Calzada Antonio Narro 1923, Saltillo, Coah., México, C.P. 25315 *Corresponding author’s email: [email protected] Abstract Calcareous soils have low availability of mineral nutrients that are essential for crops. The aim of the study was to determine the effect of citric acid (CA) applied in a nutrient solution on the composition of the pore water of a calcareous soil and its correlation with the chemical composition and quality of the tomato plants and fruits. The experimental design was a randomized block; the treatments were different concentrations of CA added to the Steiner nutrient solution. We used CA at 10- 2, 10-4 and 10-6 M and a test treatment without CA. A decrease in the electrical conductivity (EC) and oxidation-reduction potential (ORP) was observed in soil pore water (SPW), as well as changes in the concentrations of Ca2+, Mg2+, Na+ and K+ in response to the addition of CA. The concentrations of Zn, Na, Ca, and N increased in leaves, whereas in the fruit, the concentrations of Mn, Na, Mg, and P increased. Significant correlations arise between Na+ and Mg2+ (R=0.60), Na+ and Ca2+ (R=0.68), and Mg2+ and Ca2+ (R=0.76) in the soil pore water, as well as a significant negative correlation (R=-0.73) between the concentration of K+ in the soil pore water and the concentration of Mg in stems and leaves. -
Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs
(19) & (11) EP 2 246 049 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 03.11.2010 Bulletin 2010/44 A61K 31/355 (2006.01) A61K 31/56 (2006.01) C07J 53/00 (2006.01) (21) Application number: 10173114.9 (22) Date of filing: 24.05.2004 (84) Designated Contracting States: • Fikstad, David T. AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Salt Lake City, UT 84102 (US) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • Zhang, Huiping Salt Lake City, UT 844121 (US) (30) Priority: 22.05.2003 US 444935 • Giliyar, Chandrashekar Salt Lake City, UT 84102 (US) (62) Document number(s) of the earlier application(s) in accordance with Art. 76 EPC: (74) Representative: Walker, Ross Thomson 04753162.9 / 1 624 855 Potts, Kerr & Co. 15 Hamilton Square (71) Applicant: Lipocine, Inc. Birkenhead Salt Lake City, UT 84103 (US) Merseyside CH41 6BR (GB) (72) Inventors: Remarks: • Chen, Feng-Jing This application was filed on 17-08-2010 as a Salt Lake City, UT 84111 (US) divisional application to the application mentioned • Patel, Mahesh V. under INID code 62. Salt Lake City, UT 84124 (US) (54) Pharmaceutical composition and dosage forms for administration of hydrophobic drugs (57) Pharmaceutical compositions and dosage tion with improved dispersion of both the active agent forms for administration of hydrophobic drugs, particu- and the solubilizer. As a result of the improved dispersion, larly steroids, are provided. The pharmaceutical compo- the pharmaceutical composition has improved bioavail- sitions include a therapeutically effective amount of a hy- ability upon administration.